Showing results (601-610 of 744) with videos related to

Sort By:
Pageof 75
Journal of Cancer|May 23, 2015
Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active WomenLauren E McCullough, Jia Chen, Alexandra J White, et al.
Cancer Causes & Control : CCC|November 26, 2014
Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer riskLaura L Reimers, Katherine D Crew, Patrick T Bradshaw, et al.
International Journal of Cancer and Clinical Research|May 26, 2015
Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical ActivityLauren E McCullough, Jia Chen, Alexandra J White, et al.
Experimental Cell Research|December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor modelsAndrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Cancer Research|July 5, 2005
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironmentDezheng Dong, Bryce Ko, Peter Baumeister, et al.
Blood|May 3, 2002
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemiaDorina M van der Kolk, Edo Vellenga, George L Scheffer, et al.
Cancers|June 10, 2022
A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated CellsAgnes Basseville, Pierre-Christian Violet, Maryam Safari, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2009
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cellsRobert W Robey, Tomasz Obrzut, Suneet Shukla, et al.
Journal of Biomolecular Screening|February 24, 2006
A high-throughput cell-based assay for inhibitors of ABCG2 activityCurtis J Henrich, Heidi R Bokesch, Michael Dean, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Pageof 75